Purchase Order 75N95024P00668
Award Date
9/24/24
Potential Completion Date
9/23/25
Potential Value
$23K
Federal Agency
National Institute on Drug Abuse
Awardee
Qiagen, LLC
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $24,917.48 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC for RNA isolation services. The contract is not set aside and has an ultimate completion date of June 11, 2025. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academia. Qiagen has provided various products and services...
This is a $11,974.79 firm fixed-price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and scientific equipment. The contract is for the provision of RNA isolation samples to investigate new targets for the treatment of substance use disorders, in support of NIDA's ongoing experiments. No set-aside designation was used for this award. Qiagen, LLC is a division of...
This is a federal contract award to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V., by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH). The contract has a ceiling value of $8,159.50 and was awarded on September 12, 2016, with an ultimate completion date of April 30, 2017. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price pricing type. Qiagen, LLC, a foreign-owned, for-profit...
This contract was awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for preventative maintenance coverage on Qiagen's EZ2 and QIAcell laboratory equipment, with a firm fixed price of $11,517.91 and a period of performance from November 19, 2024 to November 18, 2025. Qiagen is an experienced federal contractor, having...
This is a federal contract award to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract, valued at $3,799.50, was awarded by the National Institute on Drug Abuse, a civilian agency. The contract is a Blanket Purchase Agreement (BPA) Call, with a Firm Fixed Price pricing type. Qiagen, a foreign-owned, for-profit manufacturer, will provide the agency with a range of molecular diagnostics products and services, including DNA/RNA extraction kits,...
This is a $16,800 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract is for NIDDK to acquire 1,000 QCII Translational biospecimen samples. Qiagen provides a wide range of molecular diagnostics products, services, and instrumentation to federal agencies, including the Department of Health and Human Services, Department of Defense,...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $11,437.12 contract is for the purchase of QIAGEN KITS & SUPPLIES, which are likely molecular biology products and services used to support NIAID's biomedical research, public health, and healthcare programs. Qiagen is an...
This is a $1,635 purchase order awarded by a U.S. government agency to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract does not have a set-aside designation. Qiagen provides a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs, including DNA/RNA extraction kits, next-generation sequencing, digital PCR systems, sample preparation equipment, bioinformatics software, and...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The $54,093.80 contract is for the provision of unspecified products and services, as there is no set-aside designation and no further description of the requirements. Qiagen is a long-standing federal contractor that has provided...
This $23,248.02 firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The contract is not set aside. Qiagen provides sample and assay technologies, molecular diagnostics, and related products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. This award is likely part of a larger indefinite delivery...